NCT06028334 GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI

Eligibility & Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2023-12-19 with a primary completion date of 2027-04-30.

Brief Summary

The goal of this clinical trial is to evaluate GetUp\&Go, a program for promoting increased physical activity in individuals at least 6 months post moderate-to-severe traumatic brain injury. GetUp\&Go is a remotely delivered 10-week program that includes one-on-one sessions with a therapist and a mobile health application (RehaBot). The main question is whether participants in the 10-week GetUp\&Go program increase their physical activity, and exhibit associated benefits in mental and physical health, relative to those who are put on a waitlist. * Question 1: Do participants who receive immediate treatment with GetUp\&Go show more increased physical activity, measured by accelerometer activity counts per day, and improve more on secondary outcomes, such as self-reported physical activity, emotional function, fatigue, sleep, pain, and health-related quality of life, compared to their baseline, relative to those who are put on a waitlist? * Question 2: Do participants who have continued access to the mobile health component of the intervention, RehaBot, show better maintenance of physical activity gains compared to those who no longer have access to RehaBot? * Question 3: Are individual participant characteristics associated with participants' response to the treatment program?

Eligibility Criteria

Inclusion Criteria: * Age ≥18 * TBI (open or closed), sustained at least 6 months prior to enrollment, of at least complicated-mild/moderate severity as evidenced by loss or alteration of consciousness ≥ 30 minutes; and/or post-traumatic amnesia (PTA) ≥ 24 hours, not due to intoxication/sedation and documented prospectively from the injury; and/or positive neuroimaging findings consistent with TBI * Fully weight bearing on lower limbs and able to walk indoors and outdoors without the assistance of another person * Cognitively able to participate in treatment as judged by ability to travel independently within the community * Able to communicate adequately in English for participation in the treatment protocols * Informed consent given by participant Exclusion Criteria: * Contraindications to increasing PA as judged by study physician, using an exam based on published screening tools * Medical or psychiatric instability, including current psychosis or severe uncontrolled substance misuse, as assessed using items from the SCID/MINI/ASSIST, or suicidal ideation with intent or plan, as assessed by the Columbia-Suicide Severity Rating Scale, screening version * Significant physical or intellectual disability predating the TBI * Neurodegenerative disorder, e.g., Parkinson's disease * Insufficiently inactive, i.e., reporting \> 23 weekly moderate/vigorous activity units on the Godin Leisure-Time Exercise Questionnaire * Planned surgery or other hospitalization during the succeeding 9 months * Physical or sensory disability (e.g., blindness; severe bimanual incoordination) that prevents use of a smartphone

Contact & Investigator

Frequently Asked Questions

Related Trials